Shanghai Cell Therapy Research Institute
Patent Applications and Registrations
Patent applications and USPTO patent grants for Shanghai Cell Therapy Research Institute.The latest application filed is for "antibody-modified chimeric antigen receptor modified t cell and uses thereof".
- Shanghai Cell Therapy Research Institute - Shanghai CN
| Patent | Date |
|---|---|
| Antibody-modified Chimeric Antigen Receptor Modified T Cell And Uses Thereof App 20210155702 - QIAN; Qijun ; et al. | 2021-05-27 |
| Dual-activating Costimulatory Molecule Receptor And Use Thereof App 20210046113 - QIAN; Qijun ; et al. | 2021-02-18 |
| Chimeric Promoter With High Transcriptional Activity In T-cells App 20210024927 - QIAN; Qijun ; et al. | 2021-01-28 |
| Killer Cell Capable Of Efficiently And Stably Expressing Antibody, And Uses Thereof App 20200289561 - QIAN; Qijun ; et al. | 2020-09-17 |
| Efficient And Safe Transposon Integration System And Use Thereof App 20180265890 - QIAN; Qijun ; et al. | 2018-09-20 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 